• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性肾小球肾炎患者贫血及血清甲状旁腺激素、钙和磷的评估。

Evaluation of anemia and serum iPTH, calcium, and phosphorus in patients with primary glomerulonephritis.

作者信息

Li Ya, Zhang Wen, Ren Hong, Wang Weiming, Shi Hao, Li Xiao, Chen Xiaonong, Shen Pingyan, Wu Xiaojing, Xie Jingyuan, Chen Nan

机构信息

Department of Nephrology, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, PR China.

出版信息

Contrib Nephrol. 2013;181:31-40. doi: 10.1159/000348636. Epub 2013 May 8.

DOI:10.1159/000348636
PMID:23689565
Abstract

Glomerulonephritis (GN) remains a major cause of morbidity and mortality in chronic kidney disease (CKD). Our study aimed to investigate the prevalence of anemia, abnormal serum intact parathyroid hormone (iPTH), calcium, and phosphorus in a Chinese patient population with primary GN. Medical histories and laboratory test results were collected from 2,924 patients with primary GN hospitalized in Ruijin Hospital of Shanghai between January 2003 and August 2009. The leading cause of CKD was primary glomerular diseases, which were responsible for up to 53.5% of all cases. IgA nephropathy was the most common cause, accounting for 38.7%, followed by focal segmental glomerulosclerosis (FSGS). The anemia rate of GN patients in early stages of CKD (stages 1-2 and 3) was 16-36%, and rapidly accelerated to 65.8 and 80.2% in advanced CKD stage 4 and stage 5, respectively. There was no significant decline observed in the level of serum calcium in patients with CKD stages 1-4 (p > 0.05). However, in patients with CKD stage 5 the prevalence of hypocalcaemia increased significantly (13.7%, p = 0.000). The prevalence of hyperphosphatemia did not significantly increase in patients with CKD stages 1-3 (p < 0.05), but was much higher in patients with CKD stages 4 and 5 (p = 0.001 and p = 0.021, respectively) and showed a negative correlation with renal function. Serum iPTH levels did not increase significantly in GN patients with CKD stages 1-2. The median iPTH levels were 54.7, 88.6, and 289.2 pg/ml (p = 0.000) for CKD stages 3-5, respectively, all of which showed negative correlation with renal function. The proportion of vitamin D insufficiency and deficiency increased to 29.3 and 11.2%, respectively, as the glomerular filtration rate fell below 15 ml/min/1.73 m(2). Primary glomerular disease remains the major cause of CKD in China, and complications such as anemia and metabolic bone disease are frequently present in GN patients.

摘要

肾小球肾炎(GN)仍是慢性肾脏病(CKD)发病和死亡的主要原因。我们的研究旨在调查中国原发性GN患者群体中贫血、血清完整甲状旁腺激素(iPTH)异常、钙和磷的患病率。收集了2003年1月至2009年8月期间在上海瑞金医院住院的2924例原发性GN患者的病史和实验室检查结果。CKD的主要病因是原发性肾小球疾病,占所有病例的53.5%。IgA肾病是最常见的病因,占38.7%,其次是局灶节段性肾小球硬化(FSGS)。CKD早期(1-2期和3期)GN患者的贫血率为16%-36%,在CKD晚期4期和5期迅速升至65.8%和80.2%。CKD 1-4期患者的血清钙水平未观察到显著下降(p>0.05)。然而,CKD 5期患者低钙血症的患病率显著增加(13.7%,p=0.000)。CKD 1-3期患者高磷血症的患病率没有显著增加(p<0.05),但在CKD 4期和5期患者中高磷血症的患病率要高得多(分别为p=0.001和p=0.021),并且与肾功能呈负相关。CKD 1-2期GN患者的血清iPTH水平没有显著升高。CKD 3-5期的iPTH中位数水平分别为54.7、88.6和289.2 pg/ml(p=0.000),所有这些均与肾功能呈负相关。当肾小球滤过率低于15 ml/min/1.73 m²时,维生素D不足和缺乏的比例分别增至29.3%和11.2%。原发性肾小球疾病仍是中国CKD的主要病因,贫血和代谢性骨病等并发症在GN患者中很常见。

相似文献

1
Evaluation of anemia and serum iPTH, calcium, and phosphorus in patients with primary glomerulonephritis.原发性肾小球肾炎患者贫血及血清甲状旁腺激素、钙和磷的评估。
Contrib Nephrol. 2013;181:31-40. doi: 10.1159/000348636. Epub 2013 May 8.
2
The prevalence and detection of chronic kidney disease (CKD)-related metabolic complications as a function of estimated glomerular filtration rate in the oldest old.高龄人群中估算肾小球滤过率与慢性肾脏病(CKD)相关代谢并发症的流行情况及检出率。
Arch Gerontol Geriatr. 2012 May-Jun;54(3):e419-25. doi: 10.1016/j.archger.2011.12.010. Epub 2012 Jan 20.
3
Plasma parathyroid hormone level and prevalent cardiovascular disease in CKD stages 3 and 4: an analysis from the Kidney Early Evaluation Program (KEEP).慢性肾脏病3期和4期患者的血浆甲状旁腺激素水平与心血管疾病患病率:来自肾脏早期评估项目(KEEP)的分析
Am J Kidney Dis. 2009 Apr;53(4 Suppl 4):S3-10. doi: 10.1053/j.ajkd.2008.11.029.
4
A randomized, double-blind, placebo-controlled study to assess the efficacy and safety of cinacalcet HCl in participants with CKD not receiving dialysis.一项随机、双盲、安慰剂对照研究,旨在评估盐酸西那卡塞在未接受透析的慢性肾脏病参与者中的疗效和安全性。
Am J Kidney Dis. 2009 Feb;53(2):197-207. doi: 10.1053/j.ajkd.2008.09.021. Epub 2008 Dec 24.
5
Survey of attitudes of physicians toward the current evaluation and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD).医生对慢性肾脏病-矿物质和骨异常(CKD-MBD)当前评估与治疗的态度调查
Saudi J Kidney Dis Transpl. 2010 Jan;21(1):93-101.
6
[Prevalence of chronic kidney disease in Chinese hospitalized adult patients: investigation of 13,383 cases].[中国住院成年患者慢性肾脏病的患病率:13383例病例调查]
Zhonghua Yi Xue Za Zhi. 2007 Oct 16;87(38):2672-6.
7
Relation between Calcium, Phosphorus, Calcium-Phosphorus Index and iPTH in Chronic Kidney Disease Patients.慢性肾脏病患者钙、磷、钙磷指数与全段甲状旁腺激素的关系
J Nepal Health Res Counc. 2015 Jan-Apr;13(29):50-3.
8
Achieving chronic kidney disease treatment targets in renal transplant recipients: results from a cross-sectional study in Spain.西班牙一项横断面研究的结果:肾移植受者慢性肾脏病治疗目标的达成情况
Transplantation. 2009 May 15;87(9):1340-6. doi: 10.1097/TP.0b013e3181a23837.
9
[Risk factors for anemia in the early stages of chronic kidney disease].[慢性肾脏病早期贫血的危险因素]
Ter Arkh. 2017;89(6):41-47. doi: 10.17116/terarkh201789641-47.
10
Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional study.慢性肾脏病 1 至 5 期的分泌性 Klotho 和 FGF23:一项横断面研究提示的序列。
Nephrol Dial Transplant. 2013 Feb;28(2):352-9. doi: 10.1093/ndt/gfs460. Epub 2012 Nov 4.

引用本文的文献

1
Prevalence and Treatment Patterns of Anaemia in Individuals With Chronic Kidney Disease Across Asia: A Systematic Review and Meta-Analysis.亚洲慢性肾脏病患者贫血的患病率及治疗模式:一项系统评价与荟萃分析
Nephrology (Carlton). 2025 Feb;30(2):e70002. doi: 10.1111/nep.70002.
2
Brown Tumors: The Hidden Face of Primary and Renal Hyperparathyroidism Amid Real-Life Settings.棕色瘤:现实环境中原发性和肾性甲状旁腺功能亢进的隐匿面貌。
J Clin Med. 2024 Jun 29;13(13):3847. doi: 10.3390/jcm13133847.
3
Roxadustat for treatment of anemia in a cancer patient with end-stage renal disease: A case report.
罗沙司他用于治疗一名终末期肾病癌症患者的贫血:病例报告。
World J Clin Cases. 2022 Jul 6;10(19):6587-6594. doi: 10.12998/wjcc.v10.i19.6587.
4
Serum 1,25-dihydroxyvitamin D Better Reflects Renal Parameters Than 25-hydoxyvitamin D in Patients with Glomerular Diseases.血清 1,25-二羟维生素 D 比 25-羟维生素 D 更能反映肾小球疾病患者的肾功能参数。
Int J Med Sci. 2017 Sep 4;14(11):1080-1087. doi: 10.7150/ijms.20452. eCollection 2017.
5
Prevalence, awareness, and treatment of anemia in Chinese patients with nondialysis chronic kidney disease: First multicenter, cross-sectional study.中国非透析慢性肾脏病患者贫血的患病率、知晓率及治疗情况:首项多中心横断面研究
Medicine (Baltimore). 2016 Jun;95(24):e3872. doi: 10.1097/MD.0000000000003872.